Skip to main content

Arkema shares sustainability targets

3rd October 2023

Submitted by:

Andrew Warmington

At its latest Capital Markets Day on 27 September 2023, Arkema revealed its plans to strengthen its decarbonisation initiatives as well as its financial targets. This followed the recent validation of Arkema’s emissions reduction plan by the Science-Based Targets Initiatives.

The initiative is part of an overall plan “to accelerate its organic sales growth in the medium term, by capitalising on its recent or future industrial investments in high value-added technological solutions serving fast-growing market segments supported by sustainable megatrends”. To achieve its ambitions, Arkema said that it “will place sustainability at the heart of its strategy” through five main drivers:

* Leveraging the strength of One Arkema to enhance employee empowerment and customer intimacy

* Achieving superior growth from sustainable innovation in five key submarkets driven by megatrends where it has built strong positions

* Ramping up recent capex, notably the biobased PA11 plant in Singapore and PVDF expansions, and carrying out new high-return projects in batteries, renewable energy, decarbonisation and bio-based products

* Further strengthening the portfolio with bolt-on acquisitions and finalising the divestment of the Intermediates business

* Driving manufacturing excellence including a strong focus on decarbonisation and digitalisation

By 2028, the company aims to achieve sales of around €12 billion with an elevated EBITDA margin of around 18%. This implies average organic sales growth of around 4%/year and average organic EBITDA growth at 7-8%/year in the 2024-28 period.

Arkema has also announced several initiatives driven in part by sustainability. By 2026, it will implement a patented purification technology at its acrylic monomers site in Carling, France, to improve operational efficiency, optimise resources and waste management, lower solvent use and reduce CO2 emissions by 20%. It has invested €130 million on this process, with help from the France 2030 programme.

Separately, the company is investing around €50 million to increase production of its Luperox brand of organic peroxides at Changshu, China, by 150% from early 2025. These are mainly used in as reaction initiators in polymers and components in the manufacture of photovoltaic panels. It had previously expanded Luperox capacity in India by 70% in 2022 and doubled capacity at the plant in Günzburg, Germany, which started up this summer.

Finally, Arkema is to invest a further €130 million to increase dimethyl disulfide (DMDS) capacity at Beaumont, Texas, from 2H 2025. DMDS, for which the company is the world market leader, is used mainly in biorefineries as an additive to convert vegetable oils and agro-food waste into biofuels, as well as in crop protection and as a raw material for sulfonyls, particularly in electronics. Further details were not given.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington